Interaction of the endocrine system with inflammation: a function of energy and volume regulation

被引:0
作者
Rainer H Straub
机构
[1] University Hospital,Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Division of Rheumatology, Department of Internal Medicine
来源
Arthritis Research & Therapy | / 16卷
关键词
Growth Hormone; Androgen; Thyroid Hormone; Osteocalcin; Sympathetic Nervous System;
D O I
暂无
中图分类号
学科分类号
摘要
During acute systemic infectious disease, precisely regulated release of energy-rich substrates (glucose, free fatty acids, and amino acids) and auxiliary elements such as calcium/phosphorus from storage sites (fat tissue, muscle, liver, and bone) are highly important because these factors are needed by an energy-consuming immune system in a situation with little or no food/water intake (sickness behavior). This positively selected program for short-lived infectious diseases is similarly applied during chronic inflammatory diseases. This review presents the interaction of hormones and inflammation by focusing on energy storage/expenditure and volume regulation. Energy storage hormones are represented by insulin (glucose/lipid storage and growth-related processes), insulin-like growth factor-1 (IGF-1) (muscle and bone growth), androgens (muscle and bone growth), vitamin D (bone growth), and osteocalcin (bone growth, support of insulin, and testosterone). Energy expenditure hormones are represented by cortisol (breakdown of liver glycogen/adipose tissue triglycerides/muscle protein, and gluconeogenesis; water retention), noradrenaline/adrenaline (breakdown of liver glycogen/adipose tissue triglycerides, and gluconeogenesis; water retention), growth hormone (glucogenic, lipolytic; has also growth-related aspects; water retention), thyroid gland hormones (increase metabolic effects of adrenaline/noradrenaline), and angiotensin II (induce insulin resistance and retain water). In chronic inflammatory diseases, a preponderance of energy expenditure pathways is switched on, leading to typical hormonal changes such as insulin/IGF-1 resistance, hypoandrogenemia, hypovitaminosis D, mild hypercortisolemia, and increased activity of the sympathetic nervous system and the renin-angiotensin-aldosterone system. Though necessary during acute inflammation in the context of systemic infection or trauma, these long-standing changes contribute to increased mortality in chronic inflammatory diseases.
引用
收藏
相关论文
共 621 条
[1]  
Besedovsky HO(1996)Immune-neuro-endocrine interactions Endocr Rev 17 64-102
[2]  
Del Rey A(1999)Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action Physiol Rev 79 1-71
[3]  
Turnbull AV(2006)Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens Nat Rev Immunol 6 318-328
[4]  
Rivier CL(2010)Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases J Intern Med 267 543-560
[5]  
Sternberg EM(2012)Energy metabolism and rheumatic diseases: from cell to organism Arthritis Res Ther 14 216-225
[6]  
Straub RH(2012)Evolutionary medicine and chronic inflammatory state - known and new concepts in pathophysiology J Mol Med 90 523-534
[7]  
Cutolo M(2003)Integrated evolutionary, immunological, and neuroendocrine framework for the pathogenesis of chronic disabling inflammatory diseases FASEB J 17 2176-2183
[8]  
Buttgereit F(1997)Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure Neuroendocrinology 66 54-62
[9]  
Pongratz G(1999)Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women Arterioscler Thromb Vasc Biol 19 1986-1991
[10]  
Spies CM(1999)C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 972-978